Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis
about
Combined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence?Treatment of resectable stage IIIA non-small cell lung cancer.Surgical Management of Stage IIIA Non-Small Cell Lung Cancer.PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy.Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer.
P2860
Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Neoadjuvant Chemoradiotherapy ...... l Lung Cancer: a Meta-Analysis
@ast
Neoadjuvant Chemoradiotherapy ...... l Lung Cancer: a Meta-Analysis
@en
type
label
Neoadjuvant Chemoradiotherapy ...... l Lung Cancer: a Meta-Analysis
@ast
Neoadjuvant Chemoradiotherapy ...... l Lung Cancer: a Meta-Analysis
@en
prefLabel
Neoadjuvant Chemoradiotherapy ...... l Lung Cancer: a Meta-Analysis
@ast
Neoadjuvant Chemoradiotherapy ...... l Lung Cancer: a Meta-Analysis
@en
P2093
P2860
P356
P1433
P1476
Neoadjuvant Chemoradiotherapy ...... l Lung Cancer: a Meta-Analysis
@en
P2093
Fang Fang Tou
Qing Yuan Zhang
Shan Xian Guo
Ying Lan Chen
P2860
P2888
P356
10.1038/SREP34388
P407
P577
2016-09-28T00:00:00Z